FASLG and neoplasm: This extends to MHC class II induction on M1 macrophages, which can trigger IFN-γ release by Th1 cells to further activate macrophages that express abundant antitumor cytokines and factors, such as fas ligand (FASL) and nitric oxide (NO) [18], and directly phagocytose tumor cells [92].